XML 69 R53.htm IDEA: XBRL DOCUMENT v3.24.2

Summary of Significant Accounting Policies (Details) - Schedule of Revenue by Major Source in each Segment - USD ($)	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2022
Retail drugstores
Total revenue	$ 154,541,077	$ 148,811,976	$ 164,392,555
Retail drugstores [Member]
Retail drugstores
Total revenue	75,678,470	83,351,768	84,228,492
Retail drugstores [Member] | Prescription Drugs [Member]
Retail drugstores
Total revenue	25,269,177	27,212,994	28,503,283
Retail drugstores [Member] | OTC Drugs [Member]
Retail drugstores
Total revenue	31,542,597	32,358,339	35,658,864
Retail drugstores [Member] | Nutritional Supplements [Member]
Retail drugstores
Total revenue	9,890,985	8,737,519	9,664,071
Retail drugstores [Member] | TCM [Member]
Retail drugstores
Total revenue	3,405,979	9,719,653	5,353,900
Retail drugstores [Member] | Sundry Products [Member]
Retail drugstores
Total revenue	1,129,647	1,082,168	1,544,639
Retail drugstores [Member] | Medical Devices [Member]
Retail drugstores
Total revenue	4,440,085	4,241,095	3,503,735
Online Pharmacy [Member]
Retail drugstores
Total revenue	31,857,883	32,385,089	30,219,364
Online Pharmacy [Member] | Prescription Drugs [Member]
Retail drugstores
Total revenue	9,151,412	10,606,244	10,331,652
Online Pharmacy [Member] | OTC Drugs [Member]
Retail drugstores
Total revenue	12,969,313	13,870,953	11,473,177
Online Pharmacy [Member] | Nutritional Supplements [Member]
Retail drugstores
Total revenue	4,284,556	2,740,253	2,014,011
Online Pharmacy [Member] | TCM [Member]
Retail drugstores
Total revenue	571,769	434,920	315,231
Online Pharmacy [Member] | Sundry Products [Member]
Retail drugstores
Total revenue	1,448,537	1,129,701	2,271,009
Online Pharmacy [Member] | Medical Devices [Member]
Retail drugstores
Total revenue	3,432,296	3,603,018	3,814,284
Drug Wholesale [Member]
Retail drugstores
Total revenue	47,004,724	33,075,119	49,944,699
Drug Wholesale [Member] | Prescription Drugs [Member]
Retail drugstores
Total revenue	30,784,949	21,617,636	41,116,991
Drug Wholesale [Member] | OTC Drugs [Member]
Retail drugstores
Total revenue	11,323,730	10,289,987	7,903,824
Drug Wholesale [Member] | Nutritional Supplements [Member]
Retail drugstores
Total revenue	741,883	310,909	424,210
Drug Wholesale [Member] | TCM [Member]
Retail drugstores
Total revenue	388,396	458,502	241,828
Drug Wholesale [Member] | Sundry Products [Member]
Retail drugstores
Total revenue	692,101	64,422	93,338
Drug Wholesale [Member] | Medical Devices [Member]
Retail drugstores
Total revenue	$ 3,073,665	$ 333,663	$ 164,508

X

- References

No definition available.

+ Details

Name:	cjjd_RetailDrugstoresAbstract
Namespace Prefix:	cjjd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-4

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=cjjd_RetailDrugstoresMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=cjjd_PrescriptionDrugsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=cjjd_OTCDrugsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=cjjd_NutritionalSupplementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=cjjd_TCMMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=cjjd_SundryProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=cjjd_MedicalDevicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=cjjd_OnlinePharmacyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=cjjd_DrugWholesaleMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: